These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29322632)

  • 41. Simultaneous presentation of disseminated intravascular coagulation and hemophagocytic syndrom in a patient with adult-onset Still's disease.
    Yan K; Chen T; Wang H; Tao Q; Li Y; Wang C; Xiong S; Zhai Z
    J Coll Physicians Surg Pak; 2014 May; 24(5):379-80. PubMed ID: 24848405
    [No Abstract]   [Full Text] [Related]  

  • 42. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease.
    Michel M; Duvoux C; Hezode C; Cherqui D
    J Rheumatol; 2003 Jul; 30(7):1624-5. PubMed ID: 12858469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two Severe Cases of Adult-onset Still's Disease with Persistent Pruritic Eruptions.
    Liu Y; Ikawa T; Tada Y; Tanaka T; Ohnishi T; Watanabe S; Tsukui D; Asako K; Kono H
    Acta Derm Venereol; 2018 Apr; 98(5):524-525. PubMed ID: 29362813
    [No Abstract]   [Full Text] [Related]  

  • 44. Disseminated intravascular coagulation in adult-onset Still's disease with neurological, respiratory and hepatic sequelae.
    Gibbs CJ; Foord C; Lee HA; Smith G
    Br J Hosp Med; 1993 Sep 1-14; 50(5):278-9. PubMed ID: 8220844
    [No Abstract]   [Full Text] [Related]  

  • 45. [Adult Still's disease].
    Ohta A
    Ryoikibetsu Shokogun Shirizu; 2000; (31):410-2. PubMed ID: 11269121
    [No Abstract]   [Full Text] [Related]  

  • 46. Epidemiology and outcome of articular complications in adult onset Still's disease.
    Mahfoudhi M; Shimi R; Turki S; Kheder A
    Pan Afr Med J; 2015; 22():77. PubMed ID: 26834930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of adult-onset still's disease: up to date.
    Yoo DH
    Expert Rev Clin Immunol; 2017 Sep; 13(9):849-866. PubMed ID: 28540751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic Efficacy of Leukocytapheresis in a Pregnant Woman with Refractory Adult-onset Still's Disease.
    Odai T; Isozaki T; Kasama T; Ogata H; Kinugasa E
    Intern Med; 2015; 54(17):2261-6. PubMed ID: 26328658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A C++ program to calculate sample sizes for cost-effectiveness trials in a Bayesian framework.
    Sarker SJ; Whitehead A; Khan I
    Comput Methods Programs Biomed; 2013 Jun; 110(3):471-89. PubMed ID: 23399102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The prevalence of concomitant diseases among in-patients on the subject of rheumatic gout].
    Zhukova NV
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2010; (2):19-21. PubMed ID: 20734483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical research. Advocating, the clinical way.
    Couzin J
    Science; 2005 May; 308(5724):940-2. PubMed ID: 15890856
    [No Abstract]   [Full Text] [Related]  

  • 52. Preliminary criteria for classification of adult Still's disease.
    Yamaguchi M; Ohta A; Tsunematsu T; Kasukawa R; Mizushima Y; Kashiwagi H; Kashiwazaki S; Tanimoto K; Matsumoto Y; Ota T
    J Rheumatol; 1992 Mar; 19(3):424-30. PubMed ID: 1578458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of the optimal sample size for a clinical trial accounting for the population size.
    Stallard N; Miller F; Day S; Hee SW; Madan J; Zohar S; Posch M
    Biom J; 2017 Jul; 59(4):609-625. PubMed ID: 27184938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease.
    Franchini S; Dagna L; Salvo F; Aiello P; Baldissera E; Sabbadini MG
    Arthritis Rheum; 2010 Aug; 62(8):2530-5. PubMed ID: 20506370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adult onset Still's disease: about 11 cases].
    Cheikhrouhou Abdelmoula L; Tekaya R; Ben Hadj Yahia C; Chaabouni L; Zouari R
    Tunis Med; 2007 Jun; 85(6):461-4. PubMed ID: 17644897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adaptive, group sequential and decision theoretic approaches to sample size determination.
    Mehta CR; Patel NR
    Stat Med; 2006 Oct; 25(19):3250-69; discussion 3297-301, 3302-4, 3313-4, 3326-47. PubMed ID: 16927402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adult-onset Still's disease with vesiculopustules on the hands and feet.
    Lee JB; Kim JW; Lee SS; Kim SJ; Won YH; Lee SC
    J Korean Med Sci; 2002 Dec; 17(6):852-5. PubMed ID: 12483016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sample size calculation for comparing two negative binomial rates.
    Zhu H; Lakkis H
    Stat Med; 2014 Feb; 33(3):376-87. PubMed ID: 24038204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Adult onset Still's disease with the initial symptom of pharyngalgia: a case report].
    Zhou E; Chen X; Zhang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(17):1569-70. PubMed ID: 26647549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Caution regarding the choice of standard deviations to guide sample size calculations in clinical trials.
    Chen H; Zhang N; Lu X; Chen S
    Clin Trials; 2013 Aug; 10(4):522-9. PubMed ID: 23794405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.